Examen
Page URL: https://www.bionews.org.uk/page_95899

'Enigma code' of common-cold virus may be deciphered

27 February 2017
Appeared in BioNews 890

Scientists have identified a 'hidden code' of key DNA sequences in a virus from the same family as the common cold.

The sequences, which are required to assemble the virus, appear to be identical in all strains and are dispersed across the genome, raising the possibility of a new drug target to treat all strains of a virus.

'Previously scientists have assumed that the signals regulating the assembly of a virus were located in a unique area of the genome,' said Professor Reidun Twarock, a mathematical biologist at the University of York, and co-author of the study. 'Using a combination of biological insight and mathematical modelling, our study suggests that, by contrast, the mechanism relies on multiple dispersed sites in the genome that act together in a cooperative way to enable efficient virus formation.'

The regions were identified in the human parechovirus, a member of the picornavirus family, which includes the viruses responsible for the common cold and polio. Scientists at the Universities of Leeds and York had previously identified these regions in a similar plant virus.

Standard vaccines are designed to treat single strains of a virus, but a drug targeting these regions could be effective against all strains.

'The coding works like the cogwheels in a Swiss watch,' said Professor Peter Stockley from the University of Leeds, a co-author of the study. 'We now need a drug that has the same effect as pouring sand into the watch; every part of the viral mechanism could be disabled.'

The team now plan to screen potential antiviral drugs targeting these regions. Professor Sarah Butcher of the University of Helsinki, and co-author of the study, said: 'This new research means that treatment would be less likely to trigger drug resistance, which is currently one of the major problems in antiviral therapy. This discovery could be a great leap forward in curing a host of conditions.'

Professor Peter Openshaw of Imperial College London, who was not involved in the study, said it was 'a novel avenue to be explored, but a long way from finding cures for the common cold'. He cautioned that it was not yet known if the results were applicable to all related viruses, nor if antivirals would be effective in short-term infections like those caused by common cold viruses.

The study was published in Nature Communications.

SOURCES & REFERENCES
Common cold cure a step closer after scientists 'crack' genetic code
The Telegraph |  23 February 2017
Could THIS be the end of the common cold? Scientists crack its 'enigma code' and say a treatment could be available in 10 years
Mail Online |  23 February 2017
Genomic RNA folding mediates assembly of human parechovirus
Nature Communications |  23 February 2017
Scientists close in on cracking 'Enigma code' of common cold
University of York (press release) |  23 February 2017
Scientists make major breakthrough that could pave the way for cure to common cold
Evening Standard |  23 February 2017
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 July 2016 - by Dr Lanay Griessner 
A little-known virus has been found in the uteruses of around half of women with unexplained infertility, a study has found...
7 March 2016 - by Dr Özge Özkaya 
Ancient viral DNA could be helping our immune system fight off infections from modern viruses and other pathogens...
14 September 2015 - by Dr Charlotte Warren-Gash 
A key gene that governs the severity of influenza infections has been identified...
30 March 2015 - by Dr James Heather 
A report has found that rare mutations in a single gene made one girl genetically susceptible to severe influenza infection...
8 December 2014 - by Fiona Ibanichuka 
The US Centers for Disease Control has released a health advisory warning clinicians that flu vaccines will have diminished effectiveness against one strain currently circulating in the US as it has mutated to become resistant...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.